Clinical Trials Sponsored by Menicon Co., Ltd.

Total 10303 results

TCI Co., Ltd.

Completed

Efficacy Evaluation of Triple up® Collagen Drink on Skin Condition

Skin Condition

Taiwan
RemeGen Co., Ltd.

Completed

A Study of RC48-ADC in Subjects With HER2-Positive Advanced Malignant Solid Tumors

Solid Tumors

China
Huons Co., Ltd.

Unknown

A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity

Post Stroke Upper Limb Spasticity

Korea, Republic of
Huons Co., Ltd.

Completed

HU007 Eye Drops in Patients With Dry Eye Syndrome

Dry Eye Syndromes

Korea, Republic of
Qurient Co., Ltd.

Completed

Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients

Atopic Dermatitis

United States
NanoCarrier Co., Ltd.

Completed

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer

Solid Tumors

United States, Romania, Italy, Bulgaria, Poland
Helixmith Co., Ltd.

Completed

Gene Therapy for Painful Diabetic Neuropathy

Painful Diabetic Neuropathy

United States
Helixmith Co., Ltd.

Withdrawn

Gene Therapy for the Treatment of Chronic Stable Angina

Myocardial Ischemia

United States
Helixmith Co., Ltd.

Completed

Safety Study of Gene Therapy for Ischemic Heart Disease in Korea

Ischemic Heart Disease

Korea, Republic of
Helixmith Co., Ltd.

Unknown

Gene Therapy for Chronic Granulomatous Disease in Korea

Chronic Granulomatous Disease

Korea, Republic of
RemeGen Co., Ltd.

Completed

A Phase II Study of RC48-ADC in Subjects With HER2 Positive Metastatic or Unresectable Urothelial Cancer

Advanced Cancer | Urothelial Carcinoma

China
InventisBio Co., Ltd

Completed

Food Effect Study of D-0502 Tablet in Healthy Volunteers

Breast Cancer

United States
JIMRO Co., Ltd.

Completed

Thrombectomy Revascularization of Intracranial Vessel OcclusioN by Originating From Japan (TRON1-Japan) (TRON1-Japan)

Acute Ischemic Stroke

Japan
Pharmicell Co., Ltd.

Completed

Safety Study of Clinical Cell Transplant Therapy Using Hearticellgram-AMI for Patients With Acute Myocardial Infarction

Acute Myocardial Infarction
PegBio Co., Ltd.

Completed

MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM

Type2 Diabetes Mellitus

United States
Huons Co., Ltd.

Unknown

The Safety and Efficacy Study of Hutox Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

Korea, Republic of
Huons Co., Ltd.

Unknown

Clinical Trial to Assess the Safety and Pharmacokinetics of RDG-17012 Capsule and Pradaxa® Capsule in Healthy Male Volunteers

Healthy

Korea, Republic of
Huons Co., Ltd.

Completed

The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Glabellar Lines

Korea, Republic of
Huons Co., Ltd.

Completed

Clinical Trial to Assess the Safety and Pharmacokinetics of HUG116 Tablet and Viread® Tablet in Healthy Male Volunteers

Healthy

Korea, Republic of
Anterogen Co., Ltd.

Completed

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial

Burn

Korea, Republic of
CanBas Co. Ltd.

Completed

Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC) (CBP08-02)

Metastatic Non-squamous Non Small Cell Lung Cancer

United States
PegBio Co., Ltd.

Completed

Continuous Multiple Dose PB-119 Injection in Health Volunteers

Type2 Diabetes Mellitus

China
Qurient Co., Ltd.

Completed

A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Single Doses of Q203 in Normal, Healthy, Male and Female Volunteers

Healthy Volunteers

United States
Maruho Co., Ltd.

Completed

A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.

Cutaneous Warts

Netherlands
Maruho Co., Ltd.

Completed

Phase III Study of ASP2151 in Herpes Simplex Patients

Herpes Simplex

Japan
Huons Co., Ltd.

Completed

Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject

Hypertension
Huons Co., Ltd.

Completed

Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients

Non-alcoholic Fatty Liver Disease

Korea, Republic of
Nidek Co. LTD.

Completed

OCT Agreement and Crossed Precision Study

Glaucoma | Retinal Disease | Corneal Disease

United States
Maruho Co., Ltd.

Completed

A 21 Day Pharmacokinetics Study in Papulopustular Rosacea

Papulopustular Rosacea

United States
Genewel Co., Ltd

Unknown

Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy (GUARDIX-FL)

Genital Diseases, Female

Korea, Republic of
Nidek Co. LTD.

Completed

Prospective Comparative Clinical Study to Investigate the Use of the NON CONTACT TONO/PACHYMETER NT-530P

IOP Ranges(mmHg): 7 to 16, >16 to <23, and 23 or More

Japan
HomeoTherapy Co., Ltd

Completed

Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD) (Homeo-GH)

Graft-vs-Host Disease

Korea, Republic of
Medipost Co Ltd.

Completed

The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease

Dementia of the Alzheimer's Type

Korea, Republic of
Maruho Co., Ltd.

Completed

Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis

Atopic Dermatitis

France, Germany, Poland, United Kingdom
Anterogen Co., Ltd.

Completed

Safety and Efficacy of Autologous Cultured Adipocytes in Patient With Depressed Scar

Depressed Scar

Korea, Republic of
Kyowa Kirin Korea Co., Ltd.

Recruiting

Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients

FGF23-related Hypophosphataemic Rickets and Osteomalacia

Korea, Republic of
Kyowa Kirin Korea Co., Ltd.

Recruiting

Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea Patients

Hyperphosphatemia

Korea, Republic of
Sinovac Life Sciences Co., Ltd.

Recruiting

SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People

COVID-19

China
Shenzhen Kexing Pharmaceutical Co., Ltd.

Recruiting

Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Recruiting

Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Pneumococcal Infections

China
Kyowa Kirin Korea Co., Ltd.

Completed

An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)

Breast Neoplasm Female | Breast Cancer Female

Korea, Republic of
Sinovac Life Sciences Co., Ltd.

Active, not recruiting

Immunogenicity，Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Completed

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents

COVID-19

China
Shenzhen Kexing Pharmaceutical Co., Ltd.

Completed

Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19

COVID-19

China
Beijing Mabworks Biotech Co., Ltd.
Betta Pharmaceuticals Co., Ltd.

Completed

mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Sinovac Life Sciences Co., Ltd.

Completed

Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19

COVID-19

China
Otsuka Pharmaceutical Co., Ltd.
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

Taiwan, Korea, Republic of, Japan
Shijiazhuang Yiling Pharmaceutical Co. Ltd
Tigermed Consulting Co., Ltd

Unknown

A Study of XY0206 in Subjects With Advanced or Metastatic Solid Tumours

Advanced or Metastatic Solid Tumours

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Tigermed Consulting Co., Ltd

Completed

Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma

HCC

China
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor

Solid Tumor

Korea, Republic of

3

Subscribe